(Q28365007)

2

0 references

J M Berthelot

3

0 references

W Flanagan

4

0 references

M C Wolfson

5

0 references

D M Logan

6

0 references

W K Evans

British Journal of Cancer

7

0 references

language of work or name

English

0 references

publication date

2 November 2001

0 references

published in

0 references

volume

85

0 references

issue

9

0 references

page(s)

1280-8

0 references

copyright license

Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported

start time

30 October 2001

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375241

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375241

Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375241

What makes clinical research ethical?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375241

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375241

Tamoxifen prevention of breast cancer: an instance of the fingerpost

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375241

Diagnostic and therapeutic approaches for nonmetastatic breast cancer in Canada, and their associated costs

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375241

A research registry: uses, development, and accuracy.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375241

Tamoxifen: toxicities and drug resistance during the treatment and prevention of breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375241

Using administrative data for longitudinal research: comparisons with primary data collection.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375241

Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375241

Tamoxifen should be cost-effective in reducing breast cancer risk in high-risk women

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375241

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375241

Tamoxifen for the prevention of breast cancer. Important questions remain unanswered, and existing trials should continue

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375241

Validation studies for models projecting the risk of invasive and total breast cancer incidence.

2 June 2018

1 reference

https://api.crossref.org/works/10.1054%2FBJOC.2001.2125

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1054%2FBJOC.2001.2125

Breast cancer: better care for less cost. Is it possible?

21 January 2018

1 reference

https://api.crossref.org/works/10.1054%2FBJOC.2001.2125

Is tamoxifen effective in prevention of breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1054%2FBJOC.2001.2125

Estimates of the lifetime costs of breast cancer treatment in Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1054%2FBJOC.2001.2125

Assessing uncertainty in microsimulation modelling with application to cancer screening interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1054%2FBJOC.2001.2125

Parameter sensitivity of a model of viral epidemics simulated with Monte Carlo techniques. I. Illness attack rates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1054%2FBJOC.2001.2125

POHEM--a framework for understanding and modelling the health of human populations.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2375241

Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors

27 November 2018

1 reference

12 December 2020

The cost effectiveness of tamoxifen in the prevention of breast cancer

1 reference

12 December 2020

1 reference

12 December 2020

Estimation of tamoxifen's efficacy for preventing the formation and growth of breast tumors

1 reference

12 December 2020

Re: tamoxifen prevention of breast cancer: an instance of the fingerpost

1 reference

12 December 2020

Re: tamoxifen prevention of breast cancer: an instance of the fingerpost

1 reference

12 December 2020

Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model

1 reference

12 December 2020

Effects of tamoxifen on cardiovascular risk factors in postmenopausal women

1 reference

12 December 2020

Comparison between the Effects of Tamoxifen and Toremifene on the Uterus in Postmenopausal Breast Cancer Patients

1 reference

12 December 2020